MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202637074393 A) filed by Chengdu Kanghong Biotechnologies Co. Ltd on June 16, 2026, for Double-Toxin Antibody-Drug Conjugate And Use Thereof.
Inventors include Ke, Xiao; Zhao, Yonghao; Ren, Pengfei; Lei, Gang; and Zuo, Teng.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: Provided are a double-toxin antibody-drug conjugate, and use of the antibody-drug conjugate in preparing a drug for treating cancer.
Disclaimer: Curated by HT Syndication.
